Yuzhuang Li
Key Laboratory For Stem Cells And Tissue Engineering
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Targeting heptad repeats and fusion peptide: nanoparticle vaccine elicits mucosal immune response against SARS-CoV-2 variants.
Journal: Journal of nanobiotechnology
Published: October 09, 2024
Correlation between circulating T follicular helper cell levels after infection and a decreased risk of COVID-19 re-infection.
Journal: Virologica Sinica
Published: January 25, 2024
Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology.
Journal: Journal of translational medicine
Published: December 19, 2023
Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment.
Journal: Molecular therapy oncolytics
Published: March 21, 2023
Antibody response and cross-neutralization after Omicron BA.2 infection.
Journal: Signal transduction and targeted therapy
Published: June 22, 2022
SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance.
Journal: Signal transduction and targeted therapy
Published: December 08, 2021
Development of Receptor Binding Domain (RBD)-Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS-CoV-2 Delta and Other Variants.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 23, 2021
Brd4 Regulates the Homeostasis of CD8+ T-Lymphocytes and Their Proliferation in Response to Antigen Stimulation.
Journal: Frontiers in immunology
Published: June 20, 2021
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 22, 2021
Last Updated: 09/26/2026